The Journal of Organic Chemistry
Featured Article
organic phase was concentrated through rotary evaporation and
subject to silica gel chromatography using hexane/EtOAc as the eluent
to afford compound 14 (71 g, 0.25 mol, 71% yield) as a clear oil: H
NMR (500 MHz, CDCl3) δ 7.27−7.24 (m, 4H), 7.21−7.19 (m, 1H),
4.49 (s, 2H), 3.63−3.56 (m, 14H), 3.51 (t, J = 5.0 Hz, 2H), 2.94 (t, J =
5.5 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 138.2, 128.3, 127.7,
127.5, 73.1, 72.5, 70.58, 70.57, 70.53, 70.3, 69.4, 61.6; MS (ESI) m/z
285 (M + H)+, 307 (M + Na)+, 323 (M + K)+.
(126 MHz, CDCl3) δ 138.2, 128.3, 127.6, 127.5, 73.1, 70.9, 70.7,
70.63, 70.58, 70.3, 69.7, 69.4, 43.7, 34.9; MS (ESI) m/z 566 (M +
Na)+; HRMS (ESI) calcd for C18H28Br3O4 546.9517 (M + H)+, found
546.9536.
1
25,25,25-Trifluoro-13,13-bis(((3-(3-((1,1,1,3,3,3-hexafluoro-
2-(trifluoromethyl)propan-2-yl)oxy)-2,2-bis(((1,1,1,3,3,3-hexa-
fluoro-2-(trifluoromethyl)propan-2-yl)oxy)methyl)propoxy)-
propyl)thio)-methyl)-21,21-bis(((1,1,1,3,3,3-hexafluoro-2-
(trifluoromethyl)propan-2-yl)oxy)methyl)-1-phenyl-24,24-bis-
(trifluoromethyl)-2,5,8,11,19,23-hexaoxa-15-thiapentacosane
(20). The procedure was the same as the synthesis of compound 12.
From 548 mg of 19 (1 mmol), 4 g of compound 8 (4.5 mmol), and
1.5 g of Cs2CO3 (4.5 mmol) afforded 1.7 g of 20 as a clear oil (0.59
17-Bromo-16,16-bis(bromomethyl)-1-phenyl-2,5,8,11,14-
pentaoxaheptadecane (15). To a suspension of sodium hydride
(1.2 g, 30 mmol, 60% dispersion in mineral oil) in 60 mL of dry
diglyme at 0 °C in a 100 mL flask, equipped with magnetic stirrer and
a 60 mL addition funnel, was added a solution of monobenzyl
protected tetraethylene glycol 14 (7.7 g, 27 mmol) in 15 mL dry
diglyme dropwise under nitrogen atmosphere. The resulting mixture
was stirred at 0 °C for 1 h and then at rt for another 2 h to give a
solution of sodium alcoholate. This alcoholate was added dropwise to
the refluxing solution of pentaerythritol tetrabromide 9 (11.6 g, 30
mmol) in 60 mL of diglyme at 165 °C under nitrogen atmosphere.
After the addition, the mixture was heated overnight at 165 °C and
then cooled to room temperature. The mixture was quenched with
H2O. After solvent evaporation, the residue was extracted with EtOAc
and washed with H2O, concentrated through rotary evaporation, and
subjected to silica gel chromatography using hexane/EtOAc as the
eluent to afford compound 15 (9.1 g, 15.4 mmol, 57% yield) as a clear
oil: 1H NMR (500 MHz, CDCl3) δ 7.20−7.17 (m, 4H), 7.13 (br, 1H),
4.42 (s, 2H), 3.52−3.48 (m, 5H), 3.41−3.40 (m, 9H), 3.39 (s, 8H),
3.22 (s, 2H); 13C NMR (126 MHz, CDCl3) δ 138.2, 128.2, 127.5,
127.4, 73.0, 71.8, 70.8, 70.51, 70.49, 70.46, 70.4, 70.2, 69.6, 69.3, 58.8,
43.6, 34.8; MS (ESI) m/z 606 (M + NH4)+, 611 (M + Na)+; HRMS
(ESI) calcd for C20H32Br3O5 590.9779 (M + H)+, 610.9619 (M +
Na)+, found 590.9767, 610.9990, respectively.
1
mmol, 59% yield): H NMR (500 MHz, CDCl3) δ 7.34−7.32 (m,
4H), 7.28−7.27 (m, 1H), 4.57 (s, 2H), 4.06 (s, 18H), 3.68−3.62 (m,
10H), 3.59 (d, J = 4.5 Hz, 2H), 3.46 (t, J = 6.5 Hz, 6H), 3.41 (s, 2H),
3.38 (s, 6H), 2.67 (s, 6H), 2.56 (t, J = 7.5 Hz, 6H), 1.87−1.80 (m,
6H); 13C NMR (126 MHz, CDCl3) δ 138.6, 128.6, 127.9, 127.8, 120.4
(q, J = 293.6 Hz), 80.4−79.2 (m), 73.5, 72.8, 71.0, 70.97, 70.88, 70.63,
70.61, 70.27, 70.23, 69.73, 69.71, 66.1, 65.7, 65.62, 65.60, 65.58, 46.5,
44.5, 36.7, 30.4, 29.9; 19F NMR (470 MHz, CDCl3) δ −73.27 (s); MS
(ESI) m/z 2920.8 (M + Na)+.
2-(2-(2-(Trityloxy)ethoxy)ethoxy)ethanol (21). To a CH2Cl2
(300 mL) solution of triethylene glycol (21 g, 140 mmol) was added
Et3N (20 mL, 140 mmol); then trityl chloride (19.5 g, 70 mmol) in
CH2Cl2 (100 mL) was added dropwise at 0 °C. The mixture was
stirred overnight and quenched with H2O. The organic phase was
washed with H2O and brine successively, concentrated through rotary
evaporation, and subjected to silica gel chromatography using hexane/
EtOAc as the eluent to afford compound 21 (21 g, 53.6 mmol, 77%
yield) as a clear liquid: 1H NMR (500 MHz, CDCl3) δ 7.47−7.46 (m,
6H), 7.28 (t, J = 7.0 Hz, 6H), 7.21 (t, J = 7.0 Hz, 3H), 3.68 (s, 8H),
3.60 (br, 2H), 3.25 (br, 2H), 2.57 (br, 1H); 13C NMR (126 MHz,
CDCl3) δ 144.2, 128.8, 127.9, 127.1, 86.8, 72.7, 71.0, 70.8, 70.7, 63.4,
61.9; MS (ESI) m/z 415 (M + Na)+.
14-Bromo-13,13-bis(bromomethyl)-1,1,1-triphenyl-2,5,8,11-
tetraoxatetradecane (22). The procedure was the same as synthesis
of compound 15. From 9.3 g (24 mmol) of 9, 7.84 g (20 mmol) of 21,
and 0.92 g of NaH (60% dispersion in mineral oil, 23 mmol) afforded
7.9 g of 22 (11.3 mmol, 56% yield) as a clear oil: 1H NMR (500 MHz,
CDCl3) δ 7.47−7.46 (m, 6H), 7.27 (t, J = 8.5 Hz, 6H), 7.20 (t, J = 8.0
Hz, 3H), 3.68−3.63 (m, 10H), 3.51 (s, 2H), 3.49 (s, 6H), 3.24 (t, J =
4.5 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 144.2, 128.8, 127.8,
127.0, 86.6, 71.09, 70.96, 70.82, 70.80, 70.5, 69.9, 63.5, 43.9, 35.0; MS
(ESI) m/z 719 (M + Na)+, 243 (Ph3C)+; HRMS (ESI) calcd for
C30H35Br3NaO4 720.9963 (M + Na)+, found 720.9959.
28,28,28-Trifluoro-16,16-bis(((3-(3-((1,1,1,3,3,3-hexafluoro-
2-(trifluoromethyl)propan-2-yl)oxy)-2,2-bis(((1,1,1,3,3,3-hexa-
fluoro-2-(trifluoromethyl)propan-2-yl)oxy)methyl)propoxy)-
propyl)thio)methyl)-24,24-bis(((1,1,1,3,3,3-hexafluoro-2-
(trifluoromethyl)propan-2-yl)oxy)methyl)-1-phenyl-27,27-bis-
(trifluoromethyl)-2,5,8,11,14,22,26-heptaoxa-18-thiaoctaco-
sane (16) (19F-81). To 10 mL of 2-pentanone were added the
sulfhydryl compound 8 (691 mg, 0.8 mmol), Cs2CO3 (261 mg, 0.8
mmol), and tribromide 15 (105 mg, 0.18 mmol) successively at 0 °C
under nitrogen. Then the mixture was brought to overnight reflux at
105 °C. The reaction mixture was quenched with H2O and extracted
with CH2Cl2, concentrated through rotary evaporation, and purified by
silica gel chromatography using hexane/EtOAc as the eluent to afford
1
compound 16 (270 mg, 0.092 mmol, 52% yield) as a clear oil: H
NMR (500 MHz, CDCl3) δ 7.25−7.23 (m, 4H), 7.19−7.18 (m, 1H),
4.48 (s, 2H), 3.97 (s, 18H), 3.59−3.51 (m, 14H), 3.49 (d, J = 4.5 Hz,
2H), 3.37 (t, J = 7.0 Hz, 6H), 3.31 (s, 2H), 3.29 (s, 6H), 2.58 (s, 6H),
2.46 (t, J = 6.0 Hz, 6H), 1.74 (t, J = 7.0 Hz, 6H); 13C NMR (126
MHz, CDCl3) δ 138.6, 128.5, 127.9, 127.8, 120.4 (q, J = 294.0 Hz),
80.4−79.1 (m), 73.5, 72.7, 70.92, 70.90, 70.88, 70.81, 70.5, 70.2, 69.7,
66.1, 65.7, 46.4, 44.5, 36.7, 30.4, 29.8; 19F NMR (470 MHz, CDCl3) δ
−73.38 (s); MS (ESI) m/z 2965 (M + Na)+, 2981 (M + K)+.
2-(2-(2-(Benzyloxy)ethoxy)ethoxy)ethanol (18). The proce-
dure was the same as the synthesis of compound 14. From 150 g of 17
(1 mol), 16 g of sodium hydride (0.4 mol, 60% dispersion in mineral
oil), 62.2 g of benzyl bromide (0.36 mol), 23.4 g of tetrabutylammo-
nium bromide (72.8 mmol) afforded 68 g of 18 (0.28 mol, 78% yield)
25,25,25-Trifluoro-13,13-bis(((3-(3-((1,1,1,3,3,3-hexafluoro-
2-(trifluoromethyl)propan-2-yl)oxy)-2,2-bis(((1,1,1,3,3,3-hexa-
fluoro-2-(trifluoromethyl)propan-2-yl)oxy)methyl)propoxy)-
propyl)thio)methyl)-21,21-bis(((1,1,1,3,3,3-hexafluoro-2-
(trifluoromethyl)propan-2-yl)oxy)methyl)-1,1,1-triphenyl-
24,24-bis(trifluoromethyl)-2,5,8,11,19,23-hexaoxa-15-thiapen-
tacosane (23). The procedure was the same as synthesis of
compound 16. From 14 g (16 mmol) of 8, 3.1 g (4.4 mmol) of 22,
and 5.8 g of Cs2CO3 (17.8 mmol) afforded 12 g of 23 (3.93 mmol,
1
89% yield) as a clear oil: H NMR (500 MHz, CDCl3) δ 7.48−7.46
(m, 6H), 7.30−7.25 (m, 6H), 7.23−7.21 (m, 3H), 4.04 (s, 18H),
3.66−3.64 (m, 8H), 3.58 (s, 2H), 3.44 (s, 6H), 3.39 (s, 2H), 3.36 (s,
6H), 3.24 (s, 2H), 2.65 (s, 6H), 2.54−2.53 (m, 6H), 1.82−1.81 (m,
6H); 13C NMR (126 MHz, CDCl3) δ 144.4, 129.0, 128.0, 127.1, 120.4
(q, J = 293.8 Hz), 86.8, 80.1−79.4 (m), 72.8, 71.1, 70.96, 70.94, 70.85,
70.6, 70.3, 66.1, 65.7, 65.6, 63.6, 46.4, 44.5, 36.7, 30.4, 29.8; 19F NMR
(470 MHz, CDCl3) δ −73.61 (s); MS (ESI) m/z 3073 (M + Na)+.
Compound 24. To a solution of 23 (11.6 g, 3.8 mmol) in DCM
(400 mL) was added TFA (5.8 mL, 76 mmol) dropwise at 0 °C. After
the starting material was consumed completely as monitored by TLC,
the solvent was removed through rotary evaporation and the residue
was subjected to silica gel chromatography using hexane/EtOAc as the
eluent to afford compound 24 (9.1 g, 3.24 mmol, 85% yield) as a
viscous liquid: 1H NMR (500 MHz, CDCl3) δ 4.06 (s, 18H), 3.72 (t, J
= 4.0 Hz, 2H), 3.66−3.59 (m, 10H), 3.46 (t, J = 7.5 Hz, 6H), 3.42 (s,
1
as a clear oil: H NMR (500 MHz, CDCl3) δ 7.34−7.28 (m, 4H),
7.27−7.26 (m, 1H), 4.56 (s, 2H), 3.71−3.66 (m, 8H), 3.63−3.60 (m,
2H), 3.59 (s, 2H), 2.76 (t, J = 6.0 Hz, 1H); 13C NMR (126 MHz,
CDCl3) δ 138.3, 128.5, 127.9, 127.8, 73.4, 72.7, 70.8, 70.7, 70.5, 69.5,
61.8; MS (ESI) m/z 241 (M + H)+, 263 (M + Na)+, 279 (M + K)+.
14-Bromo-13,13-bis(bromomethyl)-1-phenyl-2,5,8,11-tet-
raoxatetradecane (19). The procedure was the same as the
synthesis of compound 15. From 4.4 g of 18 (18.2 mmol), 0.84 g
of sodium hydride (21 mmol, 60% dispersion in mineral oil), and 7.74
g of 9 (20 mmol) afforded 6.1 g of 19 (11.2 mmol, 61% yield) as a
1
light yellow oil: H NMR (500 MHz, CDCl3) δ 7.32 (br, 4H), 7.26
(br, 1H), 4.55 (s, 2H), 3.67−3.62 (m, 12H), 3.51 (s, 8H); 13C NMR
8885
dx.doi.org/10.1021/jo301718y | J. Org. Chem. 2012, 77, 8879−8887